EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Oral 1,25-dihydroxyvitamin D3 minipulse therapy


Nephron 67(1): 121-122
Oral 1,25-dihydroxyvitamin D3 minipulse therapy

(PDF 0-2 workdays service: $29.90)

Accession: 032655751

PMID: 8052357



Related references

Oral minipulse therapy in vitiligo. Dermatology 190(3): 251-252, 1995

Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian Journal of Dermatology, Venereology and Leprology 80(1): 29-35, 2016

A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata. Annals of Dermatology 28(5): 569-574, 2016

Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study. Indian Journal of Dermatology 58(2): 113-116, 2013

Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination. Indian Journal of Dermatology 54(2): 124-127, 2010

Bullous Lichen Planus treated with Oral Minipulse Therapy: A Rare Case Report. Journal of Clinical and Diagnostic Research 8(12): Zd17-Zd19, 2015

A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo. Dermatology 231(3): 286-290, 2016

An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligo. Indian Journal of Dermatology, Venereology and Leprology 74(4): 357-360, 2008

Therapy of secondary hyperparathyrodism with intermittent oral bolus of 1,25 dihydroxyvitamin D3. Bone (New York) 14(1): 76, 1993

Effect of oral 1,25 dihydroxyvitamin D-3 pulse therapy on secondary hyperparathyroidism. Nichidai Igaku Zasshi 51(8): 801-806, 1992